Literature DB >> 26641267

Current Capabilities and Capacity of Ebola Treatment Centers in the United States.

Jocelyn J Herstein1, Paul D Biddinger2, Colleen S Kraft3, Lisa Saiman4, Shawn G Gibbs5, Aurora B Le1, Philip W Smith5, Angela L Hewlett5, John J Lowe1.   

Abstract

OBJECTIVE: To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features.
DESIGN: A 19-question survey was distributed electronically in April 2015. Responses were collected via email by June 2015 and analyzed in an electronic spreadsheet.
SETTING: The survey was sent to and completed by site representatives of each ETC. PARTICIPANTS: The survey was sent to all 55 ETCs; 47 (85%) responded.
RESULTS: Of the 47 responding ETCs, there are 84 isolation beds available for adults and 91 for children; of these pediatric beds, 35 (38%) are in children's hospitals. In total, the simultaneous capacity of the 47 reporting ETCs is 121 beds. On the basis of the current US census, there are 0.38 beds per million population. Most ETCs have negative pressure isolation rooms, anterooms, and a process for category A waste sterilization, although only 11 facilities (23%) have the capability to sterilize infectious waste on site.
CONCLUSIONS: Facilities developed ETCs on the basis of Centers for Disease Control and Prevention guidance, but specific capabilities are not mandated at this present time. Owing to the complex and costly nature of Ebola virus disease treatment and variability in capabilities from facility to facility, in conjunction with the lack of regulations, nationwide capacity in specialized facilities is limited. Further assessments should determine whether ETCs can adapt to safely manage other highly infectious disease threats.

Entities:  

Mesh:

Year:  2015        PMID: 26641267     DOI: 10.1017/ice.2015.300

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  9 in total

1.  Ebola Virus Disease Preparations Do Not Protect the United States Against Other Infectious Outbreaks.

Authors:  Shawn G Gibbs; John J Lowe; Aurora B Le; Jocelyn J Herstein; Paul D Biddinger
Journal:  Am J Public Health       Date:  2018-10       Impact factor: 9.308

2.  U.S. High-Level Isolation Unit Clinical Laboratory Capabilities Update.

Authors:  Jocelyn J Herstein; Peter C Iwen; Katelyn C Jelden; Paul D Biddinger; Shawn G Gibbs; Aurora B Le; Angela L Hewlett; John J Lowe
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

Review 3.  Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Authors:  Nancy E Cornish; Nancy L Anderson; Diego G Arambula; Matthew J Arduino; Andrew Bryan; Nancy C Burton; Bin Chen; Beverly A Dickson; Judith G Giri; Natasha K Griffith; Michael A Pentella; Reynolds M Salerno; Paramjit Sandhu; James W Snyder; Christopher A Tormey; Elizabeth A Wagar; Elizabeth G Weirich; Sheldon Campbell
Journal:  Clin Microbiol Rev       Date:  2021-06-09       Impact factor: 50.129

Review 4.  High-Containment Pathogen Preparation in the Intensive Care Unit.

Authors:  Brian T Garibaldi; Daniel S Chertow
Journal:  Infect Dis Clin North Am       Date:  2017-09       Impact factor: 5.982

5.  Impact of air-handling system exhaust failure on dissemination pattern of simulant pathogen particles in a clinical biocontainment unit.

Authors:  Jennifer Therkorn; David Drewry Iii; Thomas Pilholski; Kathryn Shaw-Saliba; Gregory Bova; Lisa L Maragakis; Brian Garibaldi; Lauren Sauer
Journal:  Indoor Air       Date:  2018-10-05       Impact factor: 5.770

Review 6.  Intensive Care Unit Preparedness During Pandemics and Other Biological Threats.

Authors:  Ryan C Maves; Christina M Jamros; Alfred G Smith
Journal:  Crit Care Clin       Date:  2019-07-12       Impact factor: 3.598

7.  U.S. Medical Examiner/Coroner capability to handle highly infectious decedents.

Authors:  Aurora B Le; Erin G Brooks; Lily A McNulty; James R Gill; Jocelyn J Herstein; Janelle Rios; Scott J Patlovich; Katelyn C Jelden; Kendra K Schmid; John J Lowe; Shawn G Gibbs
Journal:  Forensic Sci Med Pathol       Date:  2018-11-06       Impact factor: 2.007

8.  Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers.

Authors:  Jocelyn J Herstein; Paul D Biddinger; Shawn G Gibbs; Aurora B Le; Katelyn C Jelden; Angela L Hewlett; John J Lowe
Journal:  Emerg Infect Dis       Date:  2017-06       Impact factor: 6.883

Review 9.  A Brief History of Biocontainment.

Authors:  Theodore J Cieslak; Mark G Kortepeter
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.